# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-24-000018
Filing Date
2024-03-12
Accepted
2024-03-12 16:10:30
Documents
109
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | oncyf-20231231.htm iXBRL | 20-F | 1746983
2 | EX-2.1 | ex21exdescriptionofsecurit.htm | EX-2.1 | 3301
3 | EX-4.12 | ex412employmentagreementam.htm | EX-4.12 | 247930
4 | EX-4.13 | ex413-amylevinamendment1xe.htm | EX-4.13 | 36089
5 | EX-8.0 | ex80subsidiaries2023.htm | EX-8.0 | 3521
6 | EX-12.1 | ex121ceocertification2023.htm | EX-12.1 | 10192
7 | EX-12.2 | ex122cfocertification2023.htm | EX-12.2 | 10055
8 | EX-13.1 | ex131ceocertification2023.htm | EX-13.1 | 5018
9 | EX-13.2 | ex132cfocertification2023.htm | EX-13.2 | 4644
10 | EX-15.1 | ex151-2023mda.htm | EX-15.1 | 355851
11 | EX-15.2 | ex152ey2023consent.htm | EX-15.2 | 4656
12 | EX-16.1 | ex161-corptradingpolicyrev.htm | EX-16.1 | 64811
13 | EX-97.1 | ex971oncolyticsclawbackpol.htm | EX-97.1 | 37004
19 |  | oncolyticslogotaglinebluea.jpg | GRAPHIC | 367326
20 |  | oncolyticspipelineye2.jpg | GRAPHIC | 649958
21 |  | oncyf-20231231_g1.jpg | GRAPHIC | 148102
22 |  | oncyf-20231231_g2.jpg | GRAPHIC | 460603
| Complete submission text file | 0001129928-24-000018.txt |  | 11397107

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | oncyf-20231231.xsd | EX-101.SCH | 74482
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | oncyf-20231231_cal.xml | EX-101.CAL | 49123
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | oncyf-20231231_def.xml | EX-101.DEF | 263709
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | oncyf-20231231_lab.xml | EX-101.LAB | 586251
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | oncyf-20231231_pre.xml | EX-101.PRE | 438992
111 | EXTRACTED XBRL INSTANCE DOCUMENT | oncyf-20231231_htm.xml | XML | 1100982

Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38512 | Film No.: 24742162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)